Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Delayed Quote USD

Callan JMB Inc. (CJMB)

Compare
4.2500
+0.1500
+(3.66%)
As of April 14 at 4:00:00 PM EDT. Market Open.
Loading Chart for CJMB
  • Previous Close 4.1000
  • Open 4.1700
  • Bid 3.9400 x 100
  • Ask 4.5100 x 100
  • Day's Range 3.8300 - 4.4300
  • 52 Week Range 3.3800 - 7.7600
  • Volume 43
  • Avg. Volume 262,700
  • Market Cap (intraday) 18.885M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5400
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides perishable (non-pharma) client packaging, and technical services. The company was founded in 2006 and is headquartered in Spring Branch, Texas.

callanjmb.com

26

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CJMB

View More

Performance Overview: CJMB

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CJMB
6.25%
S&P 500 (^GSPC)
7.80%

1-Year Return

CJMB
6.25%
S&P 500 (^GSPC)
7.13%

3-Year Return

CJMB
6.25%
S&P 500 (^GSPC)
23.45%

5-Year Return

CJMB
6.25%
S&P 500 (^GSPC)
94.83%

Compare To: CJMB

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CJMB

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    18.89M

  • Enterprise Value

    17.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.77

  • Price/Book (mrq)

    5.95

  • Enterprise Value/Revenue

    2.70

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -34.95%

  • Return on Assets (ttm)

    -19.23%

  • Return on Equity (ttm)

    -38.33%

  • Revenue (ttm)

    6.56M

  • Net Income Avi to Common (ttm)

    -2.29M

  • Diluted EPS (ttm)

    -0.5400

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.1M

  • Total Debt/Equity (mrq)

    28.60%

  • Levered Free Cash Flow (ttm)

    1.25M

Research Analysis: CJMB

View More

Company Insights: CJMB

Research Reports: CJMB

View More

People Also Watch